• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aehr, Customers Bancorp, Symbotic, and ASP Isotopes and Encourages Investors to Contact the Firm

By: Bragar Eagel & Squire via GlobeNewswire
January 28, 2025 at 21:00 PM EST

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Aehr Test Systems, Inc. (NASDAQ: AEHR), Customers Bancorp, Inc. (NYSE: CUBI), Symbotic Inc. (NASDAQ: SYM), and ASP Isotopes, Inc (NASDAQ: ASPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Aehr Test Systems, Inc. (NASDAQ: AEHR)

Class Period: January 9, 2024 - March 24, 2024

Lead Plaintiff Deadline: February 3, 2025

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on Aehr’s revenue growth; (3) accordingly, Aehr’s business and/or financial prospects were overstated; and (4) as a result, Aehr’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

For more information on the Aehr class action go to: https://bespc.com/cases/AEHR

Customers Bancorp, Inc. (NYSE: CUBI)

Class Period: March 1, 2024 - August 8, 2024

Lead Plaintiff Deadline: January 31, 2025

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Customers Bancorp had inadequate anti-money laundering practices; (2) as a result, it was not in compliance with its legal obligations, which subjected it to heightened regulatory risk; and (3) as a result, defendants’ statements about Customers Bancorp’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

For more information on the Customers Bancorp class action go to: https://bespc.com/cases/CUBI

Symbotic Inc. (NASDAQ: SYM)

Class Period: February 8, 2024 - November 26, 2024

Lead Plaintiff Deadline: February 3, 2025

According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Symbotic improperly accelerated revenue recognition in its 2024 financial statements; and (2) as a result, defendants’ statements about Symbotic’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

For more information on the Symbotic class action go to: https://bespc.com/cases/SYM

ASP Isotopes, Inc (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI)

Class Period: October 30, 2024 - November 26, 2024

Lead Plaintiff Deadline: February 3, 2025

On November 26, 2024, Fuzzy Panda Research published a report which alleged that ASP Isotopes is “using old, disregarded laser enrichment technology to masquerade as a new, cutting-edge Uranium enrichment.” The report quoted a former employee of Klydon (the company ASP Isotopes purchased its “proprietary” technology from) as stating scientists “did not think it would work on Uranium.” The report revealed a series of experts interviewed stated the Company’s reported cost estimates and timeline for building its HALEU uranium facilities was misleading to the point of being “delusional.” The report further alleged the Company had significantly overstated the significance of its agreement with TerraPower, which was only a “non-binding” memorandum of understanding entered into to “put pressure on [TerraPower’s] real suppliers.” The report quoted a former TerraPower executives as stating that ASP Isotopes was “missing the manufacturing; They are missing the processes as well; They still have to develop the HALEU…the most important part.” Finally, the report revealed that the Company’s subsidiary, Quantum Leap Energy, which operates its nuclear fuels segment and to which the Company assigned the TerraPower memoranda of understanding, was completely absent from its registered South African address. The report revealed there were “zero signs” of their presence and “security guards and neighboring business about them all told us they had never heard of the companies.”

On this news, the Company’s stock price fell $1.80 or 23.53%, to close at $5.85 per share on November 26, 2024, on unusually heavy trading volume. The stock continued to fall on the subsequent trading date, falling $0.83 or 14.19%, to close at $5.02 per share on November 27, 2024, on unusually heavy trading volume.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) the Company overstated the potential effectiveness of its enrichment technology; (2) the Company overstated the development potential of its high assay low-enriched uranium facility; (3) the Company overstated the Company’s nuclear fuels operating segment results; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. 

For more information on the ASP Isotopes class action go to: https://bespc.com/cases/ASPI

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com


Primary Logo

More News

View More
Why the American Eagle Stock Rally Isn't Just Speculation
Today 17:04 EDT
Via MarketBeat
Topics Government World Trade
Tickers AEO ANF GAP
D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?
Today 16:29 EDT
Via MarketBeat
Tickers QBTS
4 Stocks Planning to Substantially Boost Buybacks After Solid Q2
Today 16:11 EDT
Via MarketBeat
Tickers BAC DHI SCHW TDY
3 Reasons Tesla's Post-Earnings Hangover Looks Like a Buy
Today 14:39 EDT
Via MarketBeat
Tickers TSLA
Taiwan Semiconductor Could Boom on This AI Action Plan
Today 13:02 EDT
Via MarketBeat
Topics Artificial Intelligence Government
Tickers NVDA TSM
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap